Verified · 2 outletsIndia
Biocon Gets US FDA Approval For Pebrilzo Breast Cancer Drug, Plans US Launch In 2028
Headline via Free Press Journal · first report 16 Nov, 18:34 IST, latest 17 Nov, 02:26 IST
What we know
2 independent news organisations have reported this story. The first report we saw came from Free Press Journal at 16 Nov, 18:34 IST; the latest is from STAT at 17 Nov, 02:26 IST. Rational Times has not independently confirmed the details: read each report through the links below.
StatusVerified
Reported by2 news organisations
First report16 Nov, 18:34 IST
Latest report17 Nov, 02:26 IST
DeskIndia
What the reports sayEach newsroom’s own summary of its report, from its feed
The FDA approved a new breast cancer drug from Roche, teeing up the launch of a medicine the company has said could become its top-selling product ever.
Quoted from the newsrooms’ own feeds, with their names and links. Rational Times has not independently confirmed the details.
The reports2 reports
- Free Press Journal Biocon Gets US FDA Approval For Pebrilzo Breast Cancer Drug, Plans US Launch In 2028
- STAT STAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for Roche
Headlines belong to the news organisations named; each links to their own report. We group reports automatically by their key words, so now and then two different stories can be grouped together, or one story split in two. Tell us about a mistake
Rational






